Oxford Cancer Biomarkers are pleased to announce the rebranding of our ColoProg ® product to OncoProg ® OXFORD, UK – April 21st, 2021 – OncoProg ® is a cutting-edge digital pathology prognosis tool that provides a more complete understanding of…
Professors David and Rachel Kerr’s proposed colorectal cancer treatment guidelines for patients during the COVID-19 era. AIMS METHODS We have modified the guidelines in such a way that we believe will decrease the TOTAL number of patients receiving chemotherapy (particularly…
Press Release Oxford Cancer Biomarkers, Tuesday 6th November 2018. OCB is pleased to announce that it is an SME partner to University Hospital Coventry and Warwickshire NHS Trust’s successful bid for the PathLAKE project. Greg Clark, UK Secretary of State…
What is rectal bleeding? Rectal bleeding (bleeding from the bottom) is common. In fact, one in four people will experience rectal bleeding in their lifetime. This could be blood on the toilet paper, blood in the poo or bloody diarrhoea.…
One in two of us will be diagnosed with some form of cancer in our lives. The good news is that more people than ever before are living with and beyond that diagnosis. The timeline of cancer has changed dramatically…